Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTRB1 | P17538 | 1/20 | 0.46 |
| ▸ | CMA1 | P23946 | 1/20 | 0.45 |
| ▸ | PKLR | P30613 | 1/20 | 0.44 |
| ▸ | FDFT1 | P37268 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | TLR2 | O60603 | 2/20 | 0.42 |
| ▸ | F2 | P00734 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | MDM4 | O15151 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | PRCP | P42785 | 1/20 | 0.41 |
| ▸ | CTSL | P07711 | 1/20 | 0.41 |
| ▸ | CTSK | P43235 | 1/20 | 0.41 |
| ▸ | GFER | P55789 | 1/20 | 0.41 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30585183 | 0.93 | CTRB1 (0.45) | CTRB1CMA1FDFT1KMT2ATLR2 | |
| SCHEMBL29566581 | 0.91 | CTRB1 (0.46) | CTRB1FDFT1KMT2AF2MDM4 | |
| SCHEMBL29749447 | 0.89 | CTRB1 (0.48) | CTRB1FDFT1KMT2AF2MDM4 | |
| SCHEMBL29750784 | 0.89 | ACE (0.45) | CTRB1FDFT1TLR2F2PRCP | |
| SCHEMBL29706288 | 0.89 | CTRB1 (0.55) | CTRB1FDFT1KMT2AF2MDM4 | |
| SCHEMBL29777648 | 0.88 | ACE (0.49) | CTRB1FDFT1TLR2F2PRCP | |
| SCHEMBL30690096 | 0.88 | FDFT1 (0.56) | CTRB1FDFT1KMT2AF2PRCP | |
| SCHEMBL29868206 | 0.88 | CTRB1 (0.56) | CTRB1CMA1KMT2AF2 | |
| SCHEMBL6434028 | 0.88 | CTRB1 (0.56) | CTRB1CMA1KMT2AF2 | |
| SCHEMBL29859475 | 0.88 | PTPN1 (0.50) | CMA1FDFT1TLR2MDM4TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114931651-B | Targeting-drug based on antibody IgG1-Fc structural domain, and preparation method and application thereof | 武汉大学 | 2025-03-04 | — | — | CN | disclosed |
| CN-116785404-A | Application of polypeptide in treatment of inhibiting NR2B and beta CaMKII and resisting depression | 南京医科大学 | 2023-09-22 | — | — | CN | disclosed |
| CN-113292508-B | Synthetic method of cyclic dipeptide containing asparagine or glutamine | 陕西慧康生物科技有限责任公司 | 2022-09-27 | — | — | CN | disclosed |
| CN-115073587-A | Synthesis process of semicontinuous liquid phase synthesis bivalirudin | 厦门胜泽泰医药科技有限公司 | 2022-09-20 | — | — | CN | disclosed |
| CN-114931651-A | Targeting-drug based on IgG1-Fc structural domain of antibody, and preparation method and application thereof | 武汉大学 | 2022-08-23 | — | — | CN | disclosed |